Insights into Concomitant Atrial Fibrillation and Chronic Kidney Disease

Area of Science:

• Nephrology
• Cardiology
• Internal Medicine

Background:

• Chronic kidney disease (CKD) is prevalent, causing irreversible renal function loss and increasing cardiovascular disease risk.
• Atrial fibrillation (AF) frequently affects CKD patients, significantly raising mortality risks.
• A complex, bidirectional relationship exists between CKD and AF, where each condition exacerbates the other.

Purpose of the Study:

• To elucidate the molecular mechanisms underlying the interplay between CKD and AF.
• To review current therapeutic strategies for managing AF in CKD patients, particularly those with end-stage renal disease.

Main Methods:

• This review synthesizes existing literature on the molecular pathways linking CKD and AF.
• It examines the challenges in therapeutic management due to altered pharmacokinetics in renal impairment.

Main Results:

• The review details potential molecular mechanisms driving the CKD-AF relationship.
• It highlights the difficulties in establishing optimal anticoagulant therapy for CKD patients with AF.

Conclusions:

• Understanding the intricate mechanisms linking CKD and AF is crucial for developing effective patient management strategies.
• Further research is needed to establish clear therapeutic guidelines for anticoagulation in CKD patients with AF, especially in end-stage renal failure.